Evidence map›Paper›PMID 42286749›Full record

ArticleJournal of medical case reports2026

Incomplete Lemierre's syndrome: a case report.

Kasper Pledts, Filip Triest, Valerie Neirynck, Elke Govaerts, Ann Verpeut, Denim Brack, Charlotte Verfaillie

Abstract readCase Reports
In one paragraph

Article in Journal of medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kasper PledtsAZ Sint-Lucas, Groenebriel 1, 9000, Ghent, Belgium. kasper.pledts@gmail.com.
Filip TriestAZ Sint-Lucas, Groenebriel 1, 9000, Ghent, Belgium.
Valerie NeirynckAZ Sint-Lucas, Groenebriel 1, 9000, Ghent, Belgium.
Elke GovaertsAZ Sint-Lucas, Groenebriel 1, 9000, Ghent, Belgium.
Ann VerpeutAZ Sint-Lucas, Groenebriel 1, 9000, Ghent, Belgium.
Denim BrackAZ Sint-Lucas, Groenebriel 1, 9000, Ghent, Belgium.
Charlotte VerfaillieAZ Sint-Lucas, Groenebriel 1, 9000, Ghent, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIncomplete Lemierre's syndrome is a bacterial oropharyngeal infection, complicated by septic emboli to end organs, but without thrombophlebitis of the internal jugular vein. We want to strengthen and raise awareness of the new concept of an incomplete Lemierre's syndrome and demonstrate that anticoagulation therapy should not be started systematically in the incomplete form. CASE PRESENTATION: We discuss the cases of one 23-year-old Belgian man and a 20-year-old Belgian Turkish man who presented to the emergency room with oropharyngeal infection and pulmonary septic emboli, without thrombophlebitis of the internal jugular vein. In both cases, Fusobacterium necrophorum was isolated and appropriate antibiotic therapy was started.

conclusionsAs these patients met all the criteria for Lemierre's syndrome except for internal jugular vein thrombophlebitis, they illustrate the relevance of the concept of incomplete Lemierre's syndrome. Both cases underline the importance to include this condition in the differential diagnosis and contribute to the discussion of whether anticoagulation should be started in patients with incomplete Lemierre's syndrome.

Indexed as

Anti-Bacterial AgentsFusobacterium InfectionsFusobacterium necrophorumLemierre SyndromePulmonary EmbolismAnticoagulantsDiagnosis, DifferentialHumansJugular VeinsMaleThrombophlebitisTreatment OutcomeYoung AdultAnti-Bacterial AgentsAnticoagulantsIncomplete Lemierre’s syndromePulmonary septic emboliThrombophlebitis

Identifiers

PMID42286749
PMCPMC13483742

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.